NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine (Q2905917): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Removed claim: co-financing rate (P837): 85.0 percentage) |
||||||
Property / co-financing rate | |||||||
| |||||||
Property / co-financing rate: 85.0 percent / rank | |||||||
Revision as of 11:27, 5 November 2022
Project Q2905917 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine |
Project Q2905917 in Portugal |
Statements
1,467,675.0 Euro
0 references
1,726,676.0 Euro
0 references
1 December 2016
0 references
30 June 2021
0 references
UNIVERSIDADE DO PORTO
0 references
Q2993198 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016385
0 references